Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Lipella Pharmaceuticals Inc (LIPO)

Lipella Pharmaceuticals Inc (LIPO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Lipella Pharmaceuticals Inc 7800 SUSQUEHANNA ST. SUITE 505 PITTSBURGH PA 15208 USA

www.lipella.com Employees: 7 P: 412-894-1853

Description:

Lipella Pharmaceuticals Inc. is a clinical-stage biotechnology company. It focused on developing new drugs by reformulating the active agents in existing generic drugs and optimizing these reformulations for new applications. Lipella Pharmaceuticals Inc. is based in PITTSBURGH.

Key Statistics

Overview:

Market Capitalization, $K 3,179
Enterprise Value, $K -111
Shares Outstanding, K 1,209
Annual Sales, $ 450 K
Annual Net Income, $ -4,620 K
Last Quarter Sales, $ 80 K
Last Quarter Net Income, $ -1,440 K
EBIT, $ -4,360 K
EBITDA, $ -4,360 K
60-Month Beta 0.31
% of Insider Shareholders 32.11%
% of Institutional Shareholders 74.31%
Float, K 821
% Float 67.89%
Short Volume Ratio 0.70

Growth:

1-Year Return -70.11%
3-Year Return 0.00%
5-Year Return 0.00%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -1.29 on 11/14/24
Next Earnings Date 11/18/24
Earnings Per Share ttm -4.25
EPS Growth vs. Prev Qtr -34.38%
EPS Growth vs. Prev Year 29.89%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%
Most Recent Split 1-8 on 11/08/24

LIPO Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -192.33%
Return-on-Assets % -154.24%
Profit Margin % -1,026.67%
Debt/Equity 0.00
Price/Sales 6.50
Price/Cash Flow N/A
Price/Book 2.01
Book Value/Share 1.21
Interest Coverage -461.00
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar